aluates Reports

$ 0.0

Automative

Global Biopharmaceutical CDMO Market Research Report 2023

Published Date: October 2023

Report Code: QYRE-Auto-33P15413

BUY CHAPTERS

Global Biopharmaceutical CDMO Market Research Report 2023

Code: QYRE-Auto-33P15413

Report

October 2023

Pages:95

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Biopharmaceutical CDMO Market

According to new survey, global Biopharmaceutical CDMO market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.

Key companies engaged in the Biopharmaceutical CDMO industry include Lonza, WuXi AppTec, Catalent, Thermo Fisher, Recipharm, Samsung Biologics, Siegfried, Delpharm and Boehringer Ingelheim, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Biopharmaceutical CDMO were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Biopharmaceutical CDMO market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Biopharmaceutical CDMO market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Biopharmaceutical CDMO Market Report

Report Metric	Details
Report Name	Biopharmaceutical CDMO Market
Segment by Type	Development and Manufacturing CDMOs Clinical Trial Material CDMOs Fill-Finish CDMOs Other
Segment by Application	Pharmaceutical Company Biotechnology Company Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Lonza, WuXi AppTec, Catalent, Thermo Fisher, Recipharm, Samsung Biologics, Siegfried, Delpharm, Boehringer Ingelheim, Aenova Group, AGC Parma Chemicals, GenScript, ProBioGen, KBI Biopharma, 3P Biopharmaceuticals, Rentschler Biopharma, Northway Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

Who are the main players in the Biopharmaceutical CDMO Market report?

Ans: The main players in the Biopharmaceutical CDMO Market are Lonza, WuXi AppTec, Catalent, Thermo Fisher, Recipharm, Samsung Biologics, Siegfried, Delpharm, Boehringer Ingelheim, Aenova Group, AGC Parma Chemicals, GenScript, ProBioGen, KBI Biopharma, 3P Biopharmaceuticals, Rentschler Biopharma, Northway Biotech

What are the Application segmentation covered in the Biopharmaceutical CDMO Market report?

Ans: The Applications covered in the Biopharmaceutical CDMO Market report are Pharmaceutical Company, Biotechnology Company, Other

What are the Type segmentation covered in the Biopharmaceutical CDMO Market report?

Ans: The Types covered in the Biopharmaceutical CDMO Market report are Development and Manufacturing CDMOs, Clinical Trial Material CDMOs, Fill-Finish CDMOs, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biopharmaceutical CDMO Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Development and Manufacturing CDMOs

1.2.3 Clinical Trial Material CDMOs

1.2.4 Fill-Finish CDMOs

1.2.5 Other

1.3 Market by Application

1.3.1 Global Biopharmaceutical CDMO Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Pharmaceutical Company

1.3.3 Biotechnology Company

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Biopharmaceutical CDMO Market Perspective (2018-2029)

2.2 Biopharmaceutical CDMO Growth Trends by Region

2.2.1 Global Biopharmaceutical CDMO Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Biopharmaceutical CDMO Historic Market Size by Region (2018-2023)

2.2.3 Biopharmaceutical CDMO Forecasted Market Size by Region (2024-2029)

2.3 Biopharmaceutical CDMO Market Dynamics

2.3.1 Biopharmaceutical CDMO Industry Trends

2.3.2 Biopharmaceutical CDMO Market Drivers

2.3.3 Biopharmaceutical CDMO Market Challenges

2.3.4 Biopharmaceutical CDMO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biopharmaceutical CDMO Players by Revenue

3.1.1 Global Top Biopharmaceutical CDMO Players by Revenue (2018-2023)

3.1.2 Global Biopharmaceutical CDMO Revenue Market Share by Players (2018-2023)

3.2 Global Biopharmaceutical CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Biopharmaceutical CDMO Revenue

3.4 Global Biopharmaceutical CDMO Market Concentration Ratio

3.4.1 Global Biopharmaceutical CDMO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical CDMO Revenue in 2022

3.5 Biopharmaceutical CDMO Key Players Head office and Area Served

3.6 Key Players Biopharmaceutical CDMO Product Solution and Service

3.7 Date of Enter into Biopharmaceutical CDMO Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Biopharmaceutical CDMO Breakdown Data by Type

4.1 Global Biopharmaceutical CDMO Historic Market Size by Type (2018-2023)

4.2 Global Biopharmaceutical CDMO Forecasted Market Size by Type (2024-2029)

5 Biopharmaceutical CDMO Breakdown Data by Application

5.1 Global Biopharmaceutical CDMO Historic Market Size by Application (2018-2023)

5.2 Global Biopharmaceutical CDMO Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Biopharmaceutical CDMO Market Size (2018-2029)

6.2 North America Biopharmaceutical CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Biopharmaceutical CDMO Market Size by Country (2018-2023)

6.4 North America Biopharmaceutical CDMO Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Biopharmaceutical CDMO Market Size (2018-2029)

7.2 Europe Biopharmaceutical CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Biopharmaceutical CDMO Market Size by Country (2018-2023)

7.4 Europe Biopharmaceutical CDMO Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Biopharmaceutical CDMO Market Size (2018-2029)

8.2 Asia-Pacific Biopharmaceutical CDMO Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Biopharmaceutical CDMO Market Size by Region (2018-2023)

8.4 Asia-Pacific Biopharmaceutical CDMO Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Biopharmaceutical CDMO Market Size (2018-2029)

9.2 Latin America Biopharmaceutical CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Biopharmaceutical CDMO Market Size by Country (2018-2023)

9.4 Latin America Biopharmaceutical CDMO Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biopharmaceutical CDMO Market Size (2018-2029)

10.2 Middle East & Africa Biopharmaceutical CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Biopharmaceutical CDMO Market Size by Country (2018-2023)

10.4 Middle East & Africa Biopharmaceutical CDMO Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Lonza

11.1.1 Lonza Company Detail

11.1.2 Lonza Business Overview

11.1.3 Lonza Biopharmaceutical CDMO Introduction

11.1.4 Lonza Revenue in Biopharmaceutical CDMO Business (2018-2023)

11.1.5 Lonza Recent Development

11.2 WuXi AppTec

11.2.1 WuXi AppTec Company Detail

11.2.2 WuXi AppTec Business Overview

11.2.3 WuXi AppTec Biopharmaceutical CDMO Introduction

11.2.4 WuXi AppTec Revenue in Biopharmaceutical CDMO Business (2018-2023)

11.2.5 WuXi AppTec Recent Development

11.3 Catalent

11.3.1 Catalent Company Detail

11.3.2 Catalent Business Overview

11.3.3 Catalent Biopharmaceutical CDMO Introduction

11.3.4 Catalent Revenue in Biopharmaceutical CDMO Business (2018-2023)

11.3.5 Catalent Recent Development

11.4 Thermo Fisher

11.4.1 Thermo Fisher Company Detail

11.4.2 Thermo Fisher Business Overview

11.4.3 Thermo Fisher Biopharmaceutical CDMO Introduction

11.4.4 Thermo Fisher Revenue in Biopharmaceutical CDMO Business (2018-2023)

11.4.5 Thermo Fisher Recent Development

11.5 Recipharm

11.5.1 Recipharm Company Detail

11.5.2 Recipharm Business Overview

11.5.3 Recipharm Biopharmaceutical CDMO Introduction

11.5.4 Recipharm Revenue in Biopharmaceutical CDMO Business (2018-2023)

11.5.5 Recipharm Recent Development

11.6 Samsung Biologics

11.6.1 Samsung Biologics Company Detail

11.6.2 Samsung Biologics Business Overview

11.6.3 Samsung Biologics Biopharmaceutical CDMO Introduction

11.6.4 Samsung Biologics Revenue in Biopharmaceutical CDMO Business (2018-2023)

11.6.5 Samsung Biologics Recent Development

11.7 Siegfried

11.7.1 Siegfried Company Detail

11.7.2 Siegfried Business Overview

11.7.3 Siegfried Biopharmaceutical CDMO Introduction

11.7.4 Siegfried Revenue in Biopharmaceutical CDMO Business (2018-2023)

11.7.5 Siegfried Recent Development

11.8 Delpharm

11.8.1 Delpharm Company Detail

11.8.2 Delpharm Business Overview

11.8.3 Delpharm Biopharmaceutical CDMO Introduction

11.8.4 Delpharm Revenue in Biopharmaceutical CDMO Business (2018-2023)

11.8.5 Delpharm Recent Development

11.9 Boehringer Ingelheim

11.9.1 Boehringer Ingelheim Company Detail

11.9.2 Boehringer Ingelheim Business Overview

11.9.3 Boehringer Ingelheim Biopharmaceutical CDMO Introduction

11.9.4 Boehringer Ingelheim Revenue in Biopharmaceutical CDMO Business (2018-2023)

11.9.5 Boehringer Ingelheim Recent Development

11.10 Aenova Group

11.10.1 Aenova Group Company Detail

11.10.2 Aenova Group Business Overview

11.10.3 Aenova Group Biopharmaceutical CDMO Introduction

11.10.4 Aenova Group Revenue in Biopharmaceutical CDMO Business (2018-2023)

11.10.5 Aenova Group Recent Development

11.11 AGC Parma Chemicals

11.11.1 AGC Parma Chemicals Company Detail

11.11.2 AGC Parma Chemicals Business Overview

11.11.3 AGC Parma Chemicals Biopharmaceutical CDMO Introduction

11.11.4 AGC Parma Chemicals Revenue in Biopharmaceutical CDMO Business (2018-2023)

11.11.5 AGC Parma Chemicals Recent Development

11.12 GenScript

11.12.1 GenScript Company Detail

11.12.2 GenScript Business Overview

11.12.3 GenScript Biopharmaceutical CDMO Introduction

11.12.4 GenScript Revenue in Biopharmaceutical CDMO Business (2018-2023)

11.12.5 GenScript Recent Development

11.13 ProBioGen

11.13.1 ProBioGen Company Detail

11.13.2 ProBioGen Business Overview

11.13.3 ProBioGen Biopharmaceutical CDMO Introduction

11.13.4 ProBioGen Revenue in Biopharmaceutical CDMO Business (2018-2023)

11.13.5 ProBioGen Recent Development

11.14 KBI Biopharma

11.14.1 KBI Biopharma Company Detail

11.14.2 KBI Biopharma Business Overview

11.14.3 KBI Biopharma Biopharmaceutical CDMO Introduction

11.14.4 KBI Biopharma Revenue in Biopharmaceutical CDMO Business (2018-2023)

11.14.5 KBI Biopharma Recent Development

11.15 3P Biopharmaceuticals

11.15.1 3P Biopharmaceuticals Company Detail

11.15.2 3P Biopharmaceuticals Business Overview

11.15.3 3P Biopharmaceuticals Biopharmaceutical CDMO Introduction

11.15.4 3P Biopharmaceuticals Revenue in Biopharmaceutical CDMO Business (2018-2023)

11.15.5 3P Biopharmaceuticals Recent Development

11.16 Rentschler Biopharma

11.16.1 Rentschler Biopharma Company Detail

11.16.2 Rentschler Biopharma Business Overview

11.16.3 Rentschler Biopharma Biopharmaceutical CDMO Introduction

11.16.4 Rentschler Biopharma Revenue in Biopharmaceutical CDMO Business (2018-2023)

11.16.5 Rentschler Biopharma Recent Development

11.17 Northway Biotech

11.17.1 Northway Biotech Company Detail

11.17.2 Northway Biotech Business Overview

11.17.3 Northway Biotech Biopharmaceutical CDMO Introduction

11.17.4 Northway Biotech Revenue in Biopharmaceutical CDMO Business (2018-2023)

11.17.5 Northway Biotech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Biopharmaceutical CDMO Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

Table 2. Key Players of Development and Manufacturing CDMOs

Table 3. Key Players of Clinical Trial Material CDMOs

Table 4. Key Players of Fill-Finish CDMOs

Table 5. Key Players of Other

Table 6. Global Biopharmaceutical CDMO Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

Table 7. Global Biopharmaceutical CDMO Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Table 8. Global Biopharmaceutical CDMO Market Size by Region (2018-2023) & (US$ Million)

Table 9. Global Biopharmaceutical CDMO Market Share by Region (2018-2023)

Table 10. Global Biopharmaceutical CDMO Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 11. Global Biopharmaceutical CDMO Market Share by Region (2024-2029)

Table 12. Biopharmaceutical CDMO Market Trends

Table 13. Biopharmaceutical CDMO Market Drivers

Table 14. Biopharmaceutical CDMO Market Challenges

Table 15. Biopharmaceutical CDMO Market Restraints

Table 16. Global Biopharmaceutical CDMO Revenue by Players (2018-2023) & (US$ Million)

Table 17. Global Biopharmaceutical CDMO Market Share by Players (2018-2023)

Table 18. Global Top Biopharmaceutical CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CDMO as of 2022)

Table 19. Ranking of Global Top Biopharmaceutical CDMO Companies by Revenue (US$ Million) in 2022

Table 20. Global 5 Largest Players Market Share by Biopharmaceutical CDMO Revenue (CR5 and HHI) & (2018-2023)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Biopharmaceutical CDMO Product Solution and Service

Table 23. Date of Enter into Biopharmaceutical CDMO Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Biopharmaceutical CDMO Market Size by Type (2018-2023) & (US$ Million)

Table 26. Global Biopharmaceutical CDMO Revenue Market Share by Type (2018-2023)

Table 27. Global Biopharmaceutical CDMO Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 28. Global Biopharmaceutical CDMO Revenue Market Share by Type (2024-2029)

Table 29. Global Biopharmaceutical CDMO Market Size by Application (2018-2023) & (US$ Million)

Table 30. Global Biopharmaceutical CDMO Revenue Market Share by Application (2018-2023)

Table 31. Global Biopharmaceutical CDMO Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 32. Global Biopharmaceutical CDMO Revenue Market Share by Application (2024-2029)

Table 33. North America Biopharmaceutical CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 34. North America Biopharmaceutical CDMO Market Size by Country (2018-2023) & (US$ Million)

Table 35. North America Biopharmaceutical CDMO Market Size by Country (2024-2029) & (US$ Million)

Table 36. Europe Biopharmaceutical CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 37. Europe Biopharmaceutical CDMO Market Size by Country (2018-2023) & (US$ Million)

Table 38. Europe Biopharmaceutical CDMO Market Size by Country (2024-2029) & (US$ Million)

Table 39. Asia-Pacific Biopharmaceutical CDMO Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

Table 40. Asia-Pacific Biopharmaceutical CDMO Market Size by Region (2018-2023) & (US$ Million)

Table 41. Asia-Pacific Biopharmaceutical CDMO Market Size by Region (2024-2029) & (US$ Million)

Table 42. Latin America Biopharmaceutical CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. Latin America Biopharmaceutical CDMO Market Size by Country (2018-2023) & (US$ Million)

Table 44. Latin America Biopharmaceutical CDMO Market Size by Country (2024-2029) & (US$ Million)

Table 45. Middle East & Africa Biopharmaceutical CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 46. Middle East & Africa Biopharmaceutical CDMO Market Size by Country (2018-2023) & (US$ Million)

Table 47. Middle East & Africa Biopharmaceutical CDMO Market Size by Country (2024-2029) & (US$ Million)

Table 48. Lonza Company Detail

Table 49. Lonza Business Overview

Table 50. Lonza Biopharmaceutical CDMO Product

Table 51. Lonza Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)

Table 52. Lonza Recent Development

Table 53. WuXi AppTec Company Detail

Table 54. WuXi AppTec Business Overview

Table 55. WuXi AppTec Biopharmaceutical CDMO Product

Table 56. WuXi AppTec Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)

Table 57. WuXi AppTec Recent Development

Table 58. Catalent Company Detail

Table 59. Catalent Business Overview

Table 60. Catalent Biopharmaceutical CDMO Product

Table 61. Catalent Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)

Table 62. Catalent Recent Development

Table 63. Thermo Fisher Company Detail

Table 64. Thermo Fisher Business Overview

Table 65. Thermo Fisher Biopharmaceutical CDMO Product

Table 66. Thermo Fisher Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)

Table 67. Thermo Fisher Recent Development

Table 68. Recipharm Company Detail

Table 69. Recipharm Business Overview

Table 70. Recipharm Biopharmaceutical CDMO Product

Table 71. Recipharm Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)

Table 72. Recipharm Recent Development

Table 73. Samsung Biologics Company Detail

Table 74. Samsung Biologics Business Overview

Table 75. Samsung Biologics Biopharmaceutical CDMO Product

Table 76. Samsung Biologics Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)

Table 77. Samsung Biologics Recent Development

Table 78. Siegfried Company Detail

Table 79. Siegfried Business Overview

Table 80. Siegfried Biopharmaceutical CDMO Product

Table 81. Siegfried Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)

Table 82. Siegfried Recent Development

Table 83. Delpharm Company Detail

Table 84. Delpharm Business Overview

Table 85. Delpharm Biopharmaceutical CDMO Product

Table 86. Delpharm Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)

Table 87. Delpharm Recent Development

Table 88. Boehringer Ingelheim Company Detail

Table 89. Boehringer Ingelheim Business Overview

Table 90. Boehringer Ingelheim Biopharmaceutical CDMO Product

Table 91. Boehringer Ingelheim Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)

Table 92. Boehringer Ingelheim Recent Development

Table 93. Aenova Group Company Detail

Table 94. Aenova Group Business Overview

Table 95. Aenova Group Biopharmaceutical CDMO Product

Table 96. Aenova Group Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)

Table 97. Aenova Group Recent Development

Table 98. AGC Parma Chemicals Company Detail

Table 99. AGC Parma Chemicals Business Overview

Table 100. AGC Parma Chemicals Biopharmaceutical CDMO Product

Table 101. AGC Parma Chemicals Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)

Table 102. AGC Parma Chemicals Recent Development

Table 103. GenScript Company Detail

Table 104. GenScript Business Overview

Table 105. GenScript Biopharmaceutical CDMO Product

Table 106. GenScript Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)

Table 107. GenScript Recent Development

Table 108. ProBioGen Company Detail

Table 109. ProBioGen Business Overview

Table 110. ProBioGen Biopharmaceutical CDMO Product

Table 111. ProBioGen Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)

Table 112. ProBioGen Recent Development

Table 113. KBI Biopharma Company Detail

Table 114. KBI Biopharma Business Overview

Table 115. KBI Biopharma Biopharmaceutical CDMO Product

Table 116. KBI Biopharma Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)

Table 117. KBI Biopharma Recent Development

Table 118. 3P Biopharmaceuticals Company Detail

Table 119. 3P Biopharmaceuticals Business Overview

Table 120. 3P Biopharmaceuticals Biopharmaceutical CDMO Product

Table 121. 3P Biopharmaceuticals Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)

Table 122. 3P Biopharmaceuticals Recent Development

Table 123. Rentschler Biopharma Company Detail

Table 124. Rentschler Biopharma Business Overview

Table 125. Rentschler Biopharma Biopharmaceutical CDMO Product

Table 126. Rentschler Biopharma Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)

Table 127. Rentschler Biopharma Recent Development

Table 128. Northway Biotech Company Detail

Table 129. Northway Biotech Business Overview

Table 130. Northway Biotech Biopharmaceutical CDMO Product

Table 131. Northway Biotech Revenue in Biopharmaceutical CDMO Business (2018-2023) & (US$ Million)

Table 132. Northway Biotech Recent Development

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Biopharmaceutical CDMO Market Size Comparison by Type (2023-2029) & (US$ Million)

Figure 2. Global Biopharmaceutical CDMO Market Share by Type: 2022 VS 2029

Figure 3. Development and Manufacturing CDMOs Features

Figure 4. Clinical Trial Material CDMOs Features

Figure 5. Fill-Finish CDMOs Features

Figure 6. Other Features

Figure 7. Global Biopharmaceutical CDMO Market Size Comparison by Application (2023-2029) & (US$ Million)

Figure 8. Global Biopharmaceutical CDMO Market Share by Application: 2022 VS 2029

Figure 9. Pharmaceutical Company Case Studies

Figure 10. Biotechnology Company Case Studies

Figure 11. Other Case Studies

Figure 12. Biopharmaceutical CDMO Report Years Considered

Figure 13. Global Biopharmaceutical CDMO Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 14. Global Biopharmaceutical CDMO Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 15. Global Biopharmaceutical CDMO Market Share by Region: 2022 VS 2029

Figure 16. Global Biopharmaceutical CDMO Market Share by Players in 2022

Figure 17. Global Top Biopharmaceutical CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CDMO as of 2022)

Figure 18. The Top 10 and 5 Players Market Share by Biopharmaceutical CDMO Revenue in 2022

Figure 19. North America Biopharmaceutical CDMO Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 20. North America Biopharmaceutical CDMO Market Share by Country (2018-2029)

Figure 21. United States Biopharmaceutical CDMO Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 22. Canada Biopharmaceutical CDMO Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 23. Europe Biopharmaceutical CDMO Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 24. Europe Biopharmaceutical CDMO Market Share by Country (2018-2029)

Figure 25. Germany Biopharmaceutical CDMO Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 26. France Biopharmaceutical CDMO Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 27. U.K. Biopharmaceutical CDMO Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 28. Italy Biopharmaceutical CDMO Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. Russia Biopharmaceutical CDMO Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. Nordic Countries Biopharmaceutical CDMO Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. Asia-Pacific Biopharmaceutical CDMO Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Asia-Pacific Biopharmaceutical CDMO Market Share by Region (2018-2029)

Figure 33. China Biopharmaceutical CDMO Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. Japan Biopharmaceutical CDMO Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. South Korea Biopharmaceutical CDMO Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 36. Southeast Asia Biopharmaceutical CDMO Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 37. India Biopharmaceutical CDMO Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 38. Australia Biopharmaceutical CDMO Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 39. Latin America Biopharmaceutical CDMO Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 40. Latin America Biopharmaceutical CDMO Market Share by Country (2018-2029)

Figure 41. Mexico Biopharmaceutical CDMO Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 42. Brazil Biopharmaceutical CDMO Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. Middle East & Africa Biopharmaceutical CDMO Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. Middle East & Africa Biopharmaceutical CDMO Market Share by Country (2018-2029)

Figure 45. Turkey Biopharmaceutical CDMO Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. Saudi Arabia Biopharmaceutical CDMO Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 47. Lonza Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)

Figure 48. WuXi AppTec Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)

Figure 49. Catalent Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)

Figure 50. Thermo Fisher Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)

Figure 51. Recipharm Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)

Figure 52. Samsung Biologics Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)

Figure 53. Siegfried Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)

Figure 54. Delpharm Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)

Figure 55. Boehringer Ingelheim Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)

Figure 56. Aenova Group Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)

Figure 57. AGC Parma Chemicals Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)

Figure 58. GenScript Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)

Figure 59. ProBioGen Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)

Figure 60. KBI Biopharma Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)

Figure 61. 3P Biopharmaceuticals Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)

Figure 62. Rentschler Biopharma Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)

Figure 63. Northway Biotech Revenue Growth Rate in Biopharmaceutical CDMO Business (2018-2023)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Ocaliva Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-3Z1331

Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Cancer Drug based on PARP Inhibitor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-3P7754

Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Injectable Drugs For Type-2 Diabete Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-18M8149

Sun May 19 00:00:00 UTC 2024

Add to Cart

Global Osimertinib Drugs Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-23T4772

Sun May 19 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Biopharmaceutical CDMO Market Research Report 2023

Published Date: October 2023

Report Code: QYRE-Auto-33P15413

Global Biopharmaceutical CDMO Market Research Report 2023

FEATURED COMPANIES

Biopharmaceutical CDMO Market

Report Scope

Scope of Biopharmaceutical CDMO Market Report

FAQ for this report

Who are the main players in the Biopharmaceutical CDMO Market report?

What are the Application segmentation covered in the Biopharmaceutical CDMO Market report?

What are the Type segmentation covered in the Biopharmaceutical CDMO Market report?

FEATURED COMPANIES

RELATED REPORTS